Welcome to the international HTA database

Showing [16733 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	HAYES, Inc.	Breast cancer susceptibility 1 and 2 (BRCA1/2) sequence variant testing for susceptibility to hereditary breast cancer
2009	Agency for Healthcare Research and Quality (AHRQ)	Impact of consumer health informatics applications
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Information and communications technologies in CHF management programmes. Organizational challenges and evidence status]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Mecasermin (Increlex®)
2009	Andalusian Health Technology Assessment Area (AETSA)	[Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009	Agency for Healthcare Research and Quality (AHRQ)	Treatment of overactive bladder in women
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Information and communications technologies in mental health (Telepsychiatry)]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Filgrastim (Ratiograstim®) for the treatment of neutropenia
2009	NIHR Health Technology Assessment programme	Prostate trials office (PROTO): co-ordinating trials of new technologies in the treatment of BPH
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Physical disease in schizophrenia: systematic review and analysis of hospital records]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Endovascular treatment of cerebrovascular disease]
2009	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis and management of ductal carcinoma in situ (DCIS)
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Transient elastography (Fibroscan) for the diagnosis of liver fibrosis: a systematic review and meta-analysis]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Quetiapine prolonged-release tablets (Seroquel XL®) for the treatment of schizophrenia in adults
2009	HAYES, Inc.	AlloDerm regenerative tissue matrix (LifeCell Corp.) for postmastectomy breast reconstruction
2009	Agency for Healthcare Research and Quality (AHRQ)	Treatment of common hip fractures
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[The effectiveness of Positron Emission Tomography (PET) with 18FDG in breast cancer. A systematic review and meta-analysis]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Etravirine (Intelence®) for the treatment of HIV-1 infected, antiretroviral treatment-experienced adults in combination with a boosted protease inhibitor and other antiretroviral medicinal products
2009	HAYES, Inc.	COL1A1 and COL1A2 gene testing for osteogenesis imperfecta types I to IV
2009	HAYES, Inc.	Hippotherapy for Neuromusculoskeletal Dysfunction
2009	Agency for Healthcare Research and Quality (AHRQ)	Vitamin D and calcium: a systematic review of health outcomes
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ropinirole prolonged-release (Requip XL®) for the treatment of idiopathic Parkinson's disease
2009	HAYES, Inc.	Continuous renal replacement therapy (CRRT) versus sustained low-efficiency daily dialysis (SLED) for adults with non-trauma-related acute renal failure
2009	Agency for Healthcare Research and Quality (AHRQ)	Outcomes of community health worker interventions
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Paricalcitol (Zemplar®) capsules for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency
2009	HAYES, Inc.	Liver transplantation for obese adults
2009	HAYES, Inc.	Continuous rotation of patients with acute respiratory distress syndrome (ARDS)
2009	Agency for Healthcare Research and Quality (AHRQ)	Outcomes of genetic testing in adults with a history of venous thromboembolism
2009	NIHR Health Technology Assessment programme	Erlotinib for the treatment of relapsed non-small cell lung cancer
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Micafungin (Mycamine®) for the treatment of invasive candidiasis in adults and children
2009	HAYES, Inc.	Continuous subglottic secretion removal from the Hi-Lo endotracheal tube (Nellcor Puritan Bennett LLC) for prevention of ventilator-associated pneumonia (VAP)
2009	Agency for Healthcare Research and Quality (AHRQ)	Clinical utility of cancer family history collection in primary care
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Bivalirudin (Angiox®) for the treatment of adult patients with acute coronary syndromes planned for urgent or early intervention
2009	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of new oral antidiabetics. A systematic review of the literature and economic assessment]
2009	HAYES, Inc.	Impella recover LP 2.5 percutaneous ventricular assist device (Abiomed Inc.)
2009	Agency for Healthcare Research and Quality (AHRQ)	Complementary and alternative medicine in back pain utilization report
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for intermediate risk factors for coronary heart disease: systematic evidence synthesis
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tacrolimus (Advagraf®) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
2009	HAYES, Inc.	deCODE MI (deCODE diagnostics)
2009	HAYES, Inc.	Intravascular ultrasound (IVUS) for the assessment of peripheral artery disease (PAD) of the lower extremities
2009	Agency for Healthcare Research and Quality (AHRQ)	Maternal and neonatal outcomes of elective induction of labor
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for bilirubin encephalopathy
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aripiprazole (Abilify®) tablets for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in patients who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment
2009	University of York	A systematic review of prognostic serum markers in febrile neutropenic episodes in children and young people undergoing treatment for malignant disease (Protocol for a systematic review)
2009	HAYES, Inc.	Natalizumab (Tysabri, Biogen Idec and Elan Pharmaceuticals) for relapsing remitting multiple sclerosis
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for visual impairment in older adults: systematic review to update the 1996 U.S. Preventive Services Task Force recommendation
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aliskiren (Rasilez®) for the treatment of essential hypertension
2009	Andalusian Health Technology Assessment Area (AETSA)	[Clinical effectiveness of ozone therapies]
2009	HAYES, Inc.	Percutaneous sacroplasty for treatment of sacral insufficiency fractures
2009	VA Technology Assessment Program (VATAP)	Quality measures in surgery
2009	Agency for Healthcare Research and Quality (AHRQ)	Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ambrisentan (Volibris®) for pulmonary arterial hypertension
2009	HAYES, Inc.	Mechanical embolus removal device (Merci Retriever) (Concentric Medical Inc.) for ischemic stroke
2009	HAYES, Inc.	Prehospital/emergency department therapeutic hypothermia for out-of-hospital cardiac arrest (OHCA) in adults
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for child and adolescent depression in primary care settings: a systematic evidence review for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eculizumab (Soliris®) for the treatment of paroxysmal nocturnal haemoglobinuria
2009	HAYES, Inc.	Agento I.C. silver-coated endotracheal tube (C.R. Bard Inc.) for the prevention of ventilator- associated pneumonia (VAP)
2009	HAYES, Inc.	Robotically assisted nephrectomy for renal malignancy using the da Vinci surgical system (Intuitive Surgical Inc.) for adult patients
2009	Agency for Healthcare Research and Quality (AHRQ)	Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications. Volume 1: application of systematic review methodology to the field of nutrition
2009	Agency for Healthcare Research and Quality (AHRQ)	Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Maraviroc (Celsentri®) for treatment-experienced adults infected only with CCR5-tropic HIV-1
2009	HAYES, Inc.	Synvisc (hylan G-F 20) (Genzyme Corp.) for arthritis of the ankle
2009	Agency for Healthcare Research and Quality (AHRQ)	Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications Volume 2: issues and challenges in conducting systematic reviews to support development of nutrient reference values: workshop summary
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Anidulafungin (Ecalta®) for the treatment of invasive candidiasis in adult non-neutropenic patients
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in caring type 2 diabetes mellitus patients. Literature review and economic assessment]
2009	HAYES, Inc.	Allogeneic stem cell transplantation for chronic lymphocytic leukemia (CLL)
2009	HAYES, Inc.	Mindstreams cognitive health assessment (NeuroTrax Corp.) product suite (U.S - Clinical Edition) for assessing mild cognitive impairment
2009	HAYES, Inc.	Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2009	Agency for Healthcare Research and Quality (AHRQ)	Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications. Volume 3: reporting of systematic reviews of micronutrients and health: a critical appraisal
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Nelarabine (Atriance®) for the treatment of T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma
2009	HAYES, Inc.	Acupuncture for treatment of headache
2009	Agency for Healthcare Research and Quality (AHRQ)	Evaluating test strategies for colorectal cancer screening - age to begin, age to stop, and timing of screening intervals: a decision analysis of colorectal cancer screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET).
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Thalidomide (Thalidomide Pharmion®) in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged GE 65 years or ineligible for high dose chemotherapy
2009	Andalusian Health Technology Assessment Area (AETSA)	[Organisational models in palliative care. A comparison on consumption of resources]
2009	HAYES, Inc.	Acupuncture for treatment of postoperative pain
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Efavirenz / emtricitabine / tenofovir disoproxil (as fumarate) (Atripla®) for the treatment of HIV-1 infection in adults
2009	HAYES, Inc.	Antimicrobial central venous catheters
2009	HAYES, Inc.	Combined positron emission tomography-computed tomography (PET-CT) for lung
2009	HAYES, Inc.	Antibacterial suture for prevention of infection
2009	HAYES, Inc.	Computer-assisted cognitive-behavioral treatment for depression
2009	HAYES, Inc.	D-Cycloserine for anxiety disorders
2009	HAYES, Inc.	Direct brain tissue oxygen monitoring for traumatic brain injury
2009	HAYES, Inc.	Myotonic dystrophy types 1 and 2
2009	HAYES, Inc.	Endovascular repair of abdominal Aortic aneurysms
2009	HAYES, Inc.	Epsilon-aminocaproic acid and tranexamic acid for coronary artery bypass graft surgery
2009	HAYES, Inc.	Nebulized antibiotic therapy for chronic sinusitis
2009	HAYES, Inc.	Etanercept for ankylosing spondylitis
2009	VA Technology Assessment Program (VATAP)	Visual problems in traumatic brain injury
2009	HAYES, Inc.	NK pressure-specified sensory device (Sensory Management Services LLC) for tarsal tunnel syndrome diagnosis
2009	HAYES, Inc.	Etanercept for psoriasis and psoriatic arthritis
2009	Belgian Health Care Knowledge Centre (KCE)	Magnetic Resonance Imaging: cost analysis
2009	VA Technology Assessment Program (VATAP)	Complementary and alternative therapies for post-traumatic stress disorder
2009	HAYES, Inc.	High-intensity focused ultrasound treatment for prostate cancer
2009	HAYES, Inc.	Beds and mattresses designed to prevent pressure ulcers
2009	HAYES, Inc.	NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for treatment of acute intracerebral hemorrhage
2009	HAYES, Inc.	Spinal muscular atrophy
2009	HAYES, Inc.	Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from cancers of the lower gastrointestinal tract
2009	HAYES, Inc.	NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for treatment of surgical bleeding